EUS plays a pivotal role in diagnosing solid pancreatic lesions in the GCC countries, offering safe and effective lesion characterization and tissue sampling. Standardized protocols and further molecular research are warranted to enhance diagnostic precision and outcomes in pancreatic adenocarcinoma.
Ghamdi et al. (Thu,) studied this question.